Evidence map›Paper›PMID 40740680›Full record

ArticleNeuroImmune pharmacology and therapeutics2025

Pannexin-1 channels, extracellular ATP, and purinergic receptors are essential for CCR5/CXCR4 clustering and HIV entry.

David Ajasin, Stephani Velasquez, Joy Gibson, Eliana Scemes, Antonio Cibelli, David Spray, Eliseo A Eugenin

Abstract read
In one paragraph

Article in NeuroImmune pharmacology and therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David AjasinDepartment of Neurobiology, The University of Texas Medical Branch (UTMB), Galveston, TX, USA.
Stephani VelasquezDepartment of Neurobiology, The University of Texas Medical Branch (UTMB), Galveston, TX, USA.
Joy GibsonDepartment of Pediatrics Infectious Diseases at Children's Hospital, Los Angeles, CA, USA.
Eliana ScemesDepartment of Cell Biology & Anatomy, New York College, Valhalla, NY, USA.
Antonio CibelliDepartment of Cell Biology & Anatomy, New York College, Valhalla, NY, USA.
David SprayDominick P. Purpura Department of Neuroscience and Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, NY, USA.
Eliseo A EugeninDepartment of Neurobiology, The University of Texas Medical Branch (UTMB), Galveston, TX, USA.ORCID https://orcid.org/0000-0002-2925-4720

Funding

SUPPORT FOR THE ROSE F KENNEDY IDDRC P50P50HD105352 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SOPHIE MOLHOLM, Steven Upshaw Walkley · 2021 to 2026
$7.0M
NICHD NIH HHS P50 HD105352
6 · The paper itself

Abstract

Objective: The Human Immunodeficiency Virus-1 (HIV) cell entry has been well characterized with the identification of CD4 as the main receptor and CXCR4 and CCR5 as co-receptors for the virus. However, how the virus uses the cell machinery for entry and infection is still a work-in-progress. Previously, we identified that the Pannexin-1 (Panx-1) channel, extracellular ATP, and purinergic receptors axis are essential for HIV entry and replication in macrophages, but the mechanisms were not fully explored. Methods: Electrophysiology, ATP quantifications, confocal, HIV entry and replication experiments were used to determine the role of Panx-1 channels in HIV entry. Results: Here, we identified that HIV or gp120 induces Panx-1 channel opening in association with ATP secretion, purinergic activation, and CCR5/CXCR4/actin clustering to enable HIV entry. Blocking Panx-1 channel opening, ATP secretion, or purinergic signaling prevented co-receptor clustering, HIV entry, and subsequent replication in multiple cell types. Conclusion: We conclude that gp120 binding to the cell induces Panx-1 opening to promote the clustering of CCR5 or CXCR4 to the site of CD4-gp120 contact to aid viral entry.

Indexed as

AIDScurehemichannelsHIV-1viral reservoirs

Identifiers

PMID40740680
PMCPMC12304881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.